SCHMERZAUSSCHALTUNG DURCH PERKUTANE ZERVIKALE CHORDOTOMIE BEI UROLOGISCHEN PATIENTEN = SUPPRESSION DE LA DOULEUR PAR CORDOTOMIE CERVICALE PERCUTANEE CHEZ LES MALADES UROLOGIQUESFLEISCHMANN K; WANDT H.1975; UROLOGE, A; DTSCH.; DA. 1975; VOL. 14; NO 5; PP. 243-244; ABS. ANGL.; BIBL. 5 REF.Article

ZUM ZEITPUNKT DER ANGIOGRAPHIE NACH SUBARACHNOIDALBLUTUNGEN. = QUAND DOIT-ON PRATIQUER L'ANGIOGRAPHIE APRES UNE HEMORRAGIE SOUS-ARACHNOIDIENROOSEN K; BOCK WJ; WANDT H et al.1976; AKTUELLE CHIR.; DTSCH.; DA. 1976; VOL. 11; NO 3; PP. 141-146; ABS. ANGL.; BIBL. 21 REF.Article

Randomized trial of high-dose adjuvant chemotherapy with autologous hematopoietic stem-cell support versus standard-dose chemotherapy in breast cancer patients with 10 or more positive lymph nodes : overall survival after 6 years of follow-upZANDER, A. R; SCHMOOR, C; WANDT, H et al.Annals of oncology. 2008, Vol 19, Num 6, pp 1082-1089, issn 0923-7534, 8 p.Article

Concomitant granulocyte colony-stimulating factor and induction chemoradiotherapy in adult acute lymphoblastic leukemia : a randomized phase III trialOTTMANN, O. G; HOELZER, D; WANDT, H et al.Blood. 1995, Vol 86, Num 2, pp 444-450, issn 0006-4971Article

Solid tumors. I: Germ cell tumors, breast cancerWANDT, H; SIEGERT, W.Bone marrow transplantation. Supplement (Basingstoke). 1993, Vol 12, Num 4, pp S79-S81, issn 0951-3078Conference Paper

Immunohistochemical evidence of estrogen and progesterone receptors in the female lower urinary tract and comparison with the vaginaWOLF, H; WANDT, H; JONAT, W et al.Gynecologic and obstetric investigation. 1991, Vol 32, Num 4, pp 227-231, issn 0378-7346Article

A therapeutic platelet transfusion strategy is safe and feasible in patients after autologous peripheral blood stem cell transplantationWANDT, H; SCHAEFER-ECKART, K; FRANK, M et al.Bone marrow transplantation (Basingstoke). 2006, Vol 37, Num 4, pp 387-392, issn 0268-3369, 6 p.Article

Allogeneic stem cell transplantation after a fludarabine/busulfan-based reduced-intensity conditioning in patients with myelodysplastic syndrome or secondary acute myeloid leukemiaKRÖGER, N; BORNHÄUSER, M; ZANDER, A. R et al.Annals of hematology (Print). 2003, Vol 82, Num 6, pp 336-342, issn 0939-5555, 7 p.Article

Secondary acute leukemia following mitoxantrone-based high-dose chemotherapy for primary breast cancer patientsKRÖGER, N; DAMON, L; ZANDER, A. R et al.Bone marrow transplantation (Basingstoke). 2003, Vol 32, Num 12, pp 1153-1157, issn 0268-3369, 5 p.Article

Long-term follow-up confirms the benefit of all-trans retinoic acid in acute promyelocytic leukemiaFENAUX, P; CHEVRET, S; BORDESSOULE, D et al.Leukemia. 2000, Vol 14, Num 8, pp 1371-1377, issn 0887-6924Article

Sequential cycles of high-dose chemotherapy with dose escalation of carboplatin with or without paclitaxel supported by G-CSF mobilized peripheral blood progenitor cells: a phase I/II study in advanced ovarian cancerWANDT, H; BIRKMANN, J; DENZEL, T et al.Bone marrow transplantation (Basingstoke). 1999, Vol 23, Num 8, pp 763-770, issn 0268-3369Article

Allogeneic hematopoietic SCT in patients with AML following treosulfan/fludarabine conditioningCASPER, J; HOLOWIECKI, J; BLAU, I et al.Bone marrow transplantation (Basingstoke). 2012, Vol 47, Num 9, pp 1171-1177, issn 0268-3369, 7 p.Article

A randomised trial of high-dose chemotherapy in the salvage treatment of patients failing first-line platinum chemotherapy for advanced germ cell tumoursPICO, J.-L; ROSTI, G; MARANGOLO, M et al.Annals of oncology. 2005, Vol 16, Num 7, pp 1152-1159, issn 0923-7534, 8 p.Article

Salvage Treatment with paclitaxel, ifosfamide, and cisplatin plus high-dose carboplatin, etoposide, and thiotepa followed by autologous stem-cell rescue in patients with relapsed or refractory germ cell cancerRICK, O; BOKEMEYER, C; HARTMANN, F et al.Journal of clinical oncology. 2001, Vol 19, Num 1, pp 81-88, issn 0732-183XArticle

Correlation of cytogenetic, molecular cytogenetic, and clinical findings in 59 patients with ANLL or MDS and abnormalities of the short arm of chromosome 12STREUBEL, B; SAUERLAND, C; BÜCHNER, T et al.British journal of haematology. 1998, Vol 100, Num 3, pp 521-533, issn 0007-1048Article

Combination of mitoxantrone and etoposide in patients aged over 60 years with untreated acute myelogenous leukemiaEHNINGER, G; FACKLER-SCHWALBE, E; MITROU, P. S et al.Haematology and blood transfusion. 1990, Vol 33, pp 316-317, issn 0171-7111Article

A multicentre study on intensive induction and consolidation therapy in acute myelogeneous leukaemiaKURRLE, E; EHNINGER, G; WANDT, H et al.Blut. 1988, Vol 56, Num 5, pp 233-236, issn 0006-5242Article

High-dose chemotherapy with autologous hematopoietic stem-cell support compared with standard-dose chemotherapy in breast cancer patients with 10 or more positive lymph nodes: First results of a randomized trialZANDER, A. R; KRÖGER, N; THIEL, E et al.Journal of clinical oncology. 2004, Vol 22, Num 12, pp 2273-2283, issn 0732-183X, 11 p.Article

Genotypically nonidentical related donors for transplantation of patients with myelodysplastic syndromes: comparison with unrelated donor transplantation and autologous stem cell transplantationDE WITTE, T; PIKKEMAAT, F; HAROUSSEAU, J et al.Leukemia. 2001, Vol 15, Num 12, pp 1878-1884, issn 0887-6924Conference Paper

Fifty-one patients with acute myeloid leukemia and translocation t(8;21)(q22;q22) : an additional deletion in 9q is an adverse prognostic factorSCHOCH, C; HAASE, D; LÖFFLER, H et al.Leukemia. 1996, Vol 10, Num 8, pp 1288-1295, issn 0887-6924Article

Topoisomerase II activities in AML blasts and their correlation with cellular sensitivity to anthracyclines and epipodophyllotoxinesGIESELER, F; GLASMACHER, A; KÄMPFE, D et al.Leukemia. 1996, Vol 10, pp S46-S49, issn 0887-6924, SUP3Conference Paper

Results of a randomised, controlled, multicentre study of recombinant human granulocyte colony-stimulating factor (filgrastim) in patients with Hodgkin's disease and non-Hodgkin's lymphoma undergoing autologous bone marrow transplantationSCHMITZ, N; DREGER, P; ZANDER, A. R et al.Bone marrow transplantation (Basingstoke). 1995, Vol 15, Num 2, pp 261-266, issn 0268-3369Article

Consolidation treatment of high risk non-seminomatous germ cell tumor (NSGCT) with high-dose chemotherapy and ABMTWANDT, H; BIRKMANN, J; SEIFERT, M et al.Bone marrow transplantation. Supplement (Basingstoke). 1992, Vol 10, Num 2, issn 0951-3078, p. 58Conference Paper

A prospective randomized controlled trial comparing PCR-based and empirical treatment with liposomal amphotericin B in patients after allo-SCTHEBART, H; KLINGSPOR, L; ENGEL, C et al.Bone marrow transplantation (Basingstoke). 2009, Vol 43, Num 7, pp 553-561, issn 0268-3369, 9 p.Article

High-dose chemotherapy with autologous haemopoietic support for advanced ovarian cancer in first complete remission : retrospective analysis from the Solid Tumour Registry of the European Group for Blood and Marrow Transplantation (EBMT)BENGALA, C; GUARNERI, V; DEMIRER, T et al.Bone marrow transplantation (Basingstoke). 2005, Vol 36, Num 1, pp 25-31, issn 0268-3369, 7 p.Article